Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized single-blind trial of ornidazole vaginal gel for bacterial vaginosis
ChiCTR-TRC-09000616Phase 3Completed
- Sponsor
- West China Second University Hospital
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ornidazole in bacterial vaginosis (BV) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Bacteriological efficacy at 3 to 7 days after treatment and Comprehensive efficacy at 28 ± 2 days after treatment. Started Jan 1990; status: completed.
02
Drugs
ornidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR-TRC-09000616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000616.